We have developed a method for early prenatal diagnosis of molecular disorders of collagens I and 111. The method takes advantage of the fact that isolated chorionic villi contain significant amounts of collagens in their extracellular matrix (stroma) and that they synthesize collagens in vitro. After metabolic labeling of chorion villus biopsies in toto with radioactive amino acids, collagens are extracted and analyzed by SDS-PAGE. Direct staining of the gel shows collagens synthesized in vivo, whereas autoradiofluorography identifies collagens synthesized during incubation in vitro. Unlike collagens synthesized by cultured amniotic fluid cells, collagens extracted from chorionic villi are not overmodified and thus allow better identification of molecular defects. Results are available within 3 to 5 d after biopsy. Using this method, we have correctly excluded Ehlers-Danlos syndrome type IV in two pregnancies, Ehlers-Danlos syndrome type VII in one pregnancy, and lethal osteogenesis imperfecta in four pregnancies. In addition, we correctly predicted a healthy fetus and an embryo 0 1 and EDS types VII and IV are heritable connective tissue disorders associated with molecular defects of collagen I (01 and EDS VII) and collagen 111 (EDS IV) (1,2). Collagen I is a heterotrimer composed of two proal(1)-chains and one proa2(I)-chain that form a triple helix.
We have developed a method for early prenatal diagnosis of molecular disorders of collagens I and 111. The method takes advantage of the fact that isolated chorionic villi contain significant amounts of collagens in their extracellular matrix (stroma) and that they synthesize collagens in vitro. After metabolic labeling of chorion villus biopsies in toto with radioactive amino acids, collagens are extracted and analyzed by SDS-PAGE. Direct staining of the gel shows collagens synthesized in vivo, whereas autoradiofluorography identifies collagens synthesized during incubation in vitro. Unlike collagens synthesized by cultured amniotic fluid cells, collagens extracted from chorionic villi are not overmodified and thus allow better identification of molecular defects. Results are available within 3 to 5 d after biopsy. Using this method, we have correctly excluded Ehlers-Danlos syndrome type IV in two pregnancies, Ehlers-Danlos syndrome type VII in one pregnancy, and lethal osteogenesis imperfecta in four pregnancies. In addition, we correctly predicted a healthy fetus and an embryo 0 1 and EDS types VII and IV are heritable connective tissue disorders associated with molecular defects of collagen I (01 and EDS VII) and collagen 111 (EDS IV) (1,2). Collagen I is a heterotrimer composed of two proal(1)-chains and one proa2(I)-chain that form a triple helix.
The genes coding for these proa-chains, COLlAl and COLlA2, are located on chromosomes 17 and 7, respectively (3) . In contrast, collagen I11 is a homotrimer composed of three proal(II1)-chains coded for by COL3Al on chromosome 2 (3).
SSCP, single-strand conformational polymorphism
Biochemical analysis of collagens synthesized by cultured skin fibroblasts is currently the standard method for diagnostic confirmation of 01, EDS IV, and EDS VII. Cultured fibroblasts synthesize and secrete both collagens I and 111, and alterations in the structure and/or the quantity of these collagens can be demonstrated in most (although not all) patients affected with 01, EDS IV, and EDS VII.
EDS IV, EDS VII, and severe forms of 0 1 are crippling or even life-threatening conditions. For prospective parents affected by these conditions, the risk of having an affected child is 50%, whereas for parents of a sporadic patient with lethal 01, the recurrence risk is 5 to 8% (4, 5) . Because prenatal diagnosis is often requested by couples at risk, efforts have been made to develop methods for the early identification of affected fetuses by means of ultrasonography, biochemistry, and DNA analyses. Transabdominal ultrasound examination is effective in identifying fetuses with perinatally lethal 0 1 (01 type 11) by 1 4 1 7 wk gestation and most fetuses with progressively deforming 0 1 (01 type 111) by 20 wk gestation. In the absence of fractures or deformities, however, less severe forms of 01 (01 types I and IV) cannot be reliably identified by ultrasonography (1, 6) . There is no experience concerning prenatal diagnosis of EDS IV or EDS VII by ultrasound analysis, although congenital hip dislocation, an obligate feature of EDS VII, might be detectable in the third trimester (2) . Genetic linkage analysis using markers linked to COLIAI and COLIA2 has been used for the prenatal diagnosis of 01. However, this approach requires knowledge about the linkage phase and thus requires a sufficiently large and informative family. Although direct identification of the genomic mutation is most straightforward, availability of this approach is presently restricted because it requires prior elucidation of the mutation in the index case. Biochemical analysis of the collagens synthesized by cultured AFC or CVC from biopsies has been attempted with the same prerequisite, i.e. the definition of a biochemical defect in the index case. Biochemical anomalies can be identified by SDS-PAGE either as additional bands corresponding to abnormal al(1)-, a2(I)-, or al(II1)-chains (such as those induced by exonskipping mutations, deletions or insertions, or cysteine substitutions in al(1)-or al(II1)-chains) or as bands showing retarded migration because of posttranslational overmodification of a(1)-, a2(I)-, or al(II1)-chains (1) due to delayed helix formation (7) . Shapiro et al. (8) established AFC cultures at wk 21 immediately before termination of a pregnancy with radiographically diagnosed 0 1 type 11. Although they reported biochemical differences from control AFC, it has since become clear that AFC are of limited use for the prenatal diagnosis of 0 1 because they synthesize exclusively overmodified proal(1) homotrimers, a variant of procollagen I composed of three proal(1)-chains (9, 10) (see below).
Recently, CVC obtained from the placenta of a vaginally delivered 32-wk fetus were used for biochemical collagen analysis after the positive ultrasound diagnosis of lethal 0 1 at wk 19 (11). The same overmodified collagen population as in cultured skin fibroblasts was identified in the patient's CVC, but it was noted that collagen produced by control CVC was more modified than that produced by dermal fibroblasts (11).
To circumvent the problem of collagen overmodification in AFC and CVC, we studied collagen synthesis in intact CV and found that I ) collagen deposited in CV can be extracted and analyzed directly, and 2) CVS synthesize collagens I, 111, and V, which can be detected after short-term incubation with radioactive precursors. We next developed a protocol for the biochemical detection of structural defects of collagens I and 111 by short-term CVOC and applied it successfully to the study of 10 pregnancies at risk for lethal 01, EDS IV, and EDS VII, as well as to 11 control pregnancies not at known risk for collagen disorders.
METHODS
CVS fiom contml pregnancies and fiom pregnancies at risk. During the initial phase of this study, the goal of which was to ascertain de novo collagen synthesis in CV and to establish the analytical protocol, control CVS were obtained with informed consent during voluntary pregnancy termination. Prenatal diagnosis was then offered to those families in whom previous biochemical examination of fibroblast cultures from the index case had shown an unambiguous anomaly of either collagen I or collagen 111 (Table 1) . Diagnosis was performed with informed consent of the families, who understood that they were participating in an experimental study. Aliquots of one or two control CVS were usually studied in parallel. Two pregnancies at risk for EDS IV, one at risk for EDS VIIB, six at risk for 01, and 11 control pregnancies were biochemically monitored. For further details see Table 1 .
CVsampling and preparation. CVS were dissected free from maternal material and hand-delivered or sent by express mail the same day in either MEM with 10% FCS or Chang medium. The samples reached our laboratory within 24 h after they had been taken, except for one instance in which the transport took 1 wk, without significant loss of biologic activity of the specimen as judged by the incorporation of radiolabeled amino acids.
Biochemical amlysis of cell cultures. Dermal fibroblasts were cultured in MEM with 10% FCS (both from Gibco, Life Technologies, Basel, Switzerland) and grown under standard conditions (12) . A total of 250 000 cells per 35-mm dish were seeded and after 24 h were metabolically labeled for an additional 16 h with 10 pCi each of [3~]proline and [3~]glycine in the presence of 50 pg/mL ascorbate and 50 pglmL catalase. Separate harvesting and pepsinization of collagen from culture medium and cell layer were as described (12) . After SDS-gel electrophoresis (5% acrylamide; acry1:bisacryl = 3 7 5 1 ) in the presence of 0.5 M urea, the radiolabeled collagens were detected by autoradiofluorography. Two-dimensional mapping of cyanogen bromide-cleavage peptides of collagen chains (cleavage time, 90 min) was performed as described (12, 13) . Control CVC and AFC were established from CVS and amniotic fluid, respectively, grown for 3 wk, and treated like dermal fibroblasts for analysis.
Biochemicalanalysis of CVOC. Briefly, upon delivery (d I), the amount of each sample in mg was estimated by comparison with calibration photographs. CV (2CL30 mg) were washed twice in MEM without additives and incubated overnight in a mixture of 500 pL of MEM (plus antibiotics, 5 mM glutamine, and 10% dialyzed FCS), 50 p L (50 pCi) of 3~ [2] glycine, 50 p L (50 pCi) of 3~ [2, 3] proline, and 50 p L of L-ascorbate (freshly prepared at 1 mg/mL water, final concentration 75 &mL) at 37°C and 5% COz. The incubation was performed with the tubes in an upright position and the caps loosened to allow gas exchange. On d 2 the tubes were placed on ice and the villi were homogenized in their incubation me- Healthy dium with an ultrasonic cell disruptor using a microtip (Branson Ultrasonics Corp., Danbury, CT; five strokes, 50% pulse, setting 7). CV were then digested for 2 h at 20°C after addition of 65 pL of a solution of porcine pepsin (Boehringer-Mannheim, Mannheim, Germany) dissolved in 1 N HCI (1 mg/mL). The digestion was stopped by addition of 65 pL of 1N NaOH, and the suspension cleared at 2000 x g for 10 min. The supernatant was transferred to a fresh tube, and proteins were precipitated by adding Y2 volume of absolute ethanol for 2 h at -20°C. The resulting pellets were dissolved in 130 pL of sample buffer (14) supplemented with 0.5 M urea and boiled for 3 min. Niquots of 20 and 60 p,L per sample (equivalent to 5-8 mg and 15-25 mg of extracted CV, respectively) were loaded onto SDS gels. The gels were stained overnight with Coomassie Blue R-250 and destained on d 3 for 1 h for visualization of collagens deposited in vivo into the extracellular matrix (stroma). These results were documented photographically and the gels further processed for autoradiography (15) and exposed to Kodak X-AR films from d 4 to d 5, at which time fluorograms were developed to visualize collagens synthesized de novo by CV in culture.
Case report: family MED (Table I) . In this nonconsanguineous Spanish couple and respective relatives (referred to as family MED), there is no significant medical history of fractures by inadequate trauma, joint hypermobility, scleral discoloration, bone deformities, hearing loss, or dental abnormalities. The mother measures 153 cm tall and is shorter by 12-22 cm than her female first-degree relatives. X-ray examination of her spine was unremarkable. The father is 177 cm tall, approximately as tall as his male first-degree relatives.
The couple's first pregnancy (mother aged 25 y, father aged 27 y) resulted in the birth of a stillborn fetus at the 32nd gestational wk (Spain, January 1990) who reportedly had short and malformed limbs and a deformed skull. No autopsy was done, and no x-ray information was available. During the second pregnancy, bony abnormalities were sonographically detected at wk 16 and confirmed at wk 17 and 18, suggesting the presence of a severe form of 0 1 (Fig. 1, left column) . Autopsy after pregnancy termination at wk 18 revealed a macerated male fetus (hereafter referred to as fetus 11) without internal malformations but with deformities compatible with 01 type 11. Postmortem x-rays showed an unossified skull, beaded ribs with multiple fractures, and severely bowed femora and humeri due to multiple old and fresh fractures (not shown). Collagen analysis by SDS-PAGE of cultured dermal fetal fibroblasts revealed a structural collagen I defect (Fig. 2) (see below) .
Given the outcome of the first two pregnancies, additional pregnancies of this couple were considered to be at significant risk for recurrence of lethal 0 1 because of the possibility of parental mosaicism for a collagen I mutation. At wk 10 of the third pregnancy, CV sampling was performed (karyotype was normal), and collagens were analyzed according to our protocol for CVOC (see type 11: their poorly ossified skulls allowed resolution of intracerebral structures (A, D, E, C, and G) and were soft and easily deformed by the pressure of the transducer (E) in contrast to the unaffected fetus I11 (B and F). In both affected fetuses, the limbs were short and malformed. The lower limbs showed clumpy echogenic structures compatible with compressed and fractured bones of tibiae (t) and femur V) (H and J); compare them with the long and well-formed bones of the healthy fetus I11 (I). On the transthoracic section, the rib cage shows a bilateral impression due to angulation of the ribs (arrows) in the affected fetuses I1 and IV (K and M, respectively) in contrast to the regular circle described by the rib cage of unaffected fetus I11 (L). The spine is markedsp for orientation. Different magnifications of the ultrasound images shown here do not reflect the real developmental size differences between the three fetuses. above). The results predicted an unaffected fetus 111 (Fig.  2) , as did repeated ultrasound examinations (Fig. 1 , middle column); a healthy girl, now 2 y old, was born at term. The fourth pregnancy was characterized by normal ultrasound findings at wk 11, when CV sampling was performed. Karyotyping in fetus IV was normal (46,XY), whereas biochemical analysis revealed collagen I abnormalities similar to those detected in the index case, fetus I1 ( Fig. 2 ) (see below). Bony abnormalities were evident on ultrasonography repeated at wk 14 ( Fig. 1 , right column). Postabortion studies were undertaken to ascertain the molecular basis of recurrent 0 1 type I1 in family MED.
Molecular genetic studies in family MED. Total mRNA prepared from confluent fibroblast cultures by the guanidinium thiocyanate-cesium chloride method (16) was retrotranscribed to first-strand cDNA using a commercially available kit (Boehringer-Mannheim). Aliquots of cDNA were amplified by PCR using Taq polymerase (Promega, Madison, WI) and several oligonucleotide primer couples specific for the al(I)CB7, CB3, and CB8 regions of both al(1)-and a2(I)-chains in the presence of 3 2~-d~~~ (approximately 1 FCi in each 2 0 -~L reaction). For analysis of SSCP, the PCR products were diluted with formamide loading buffer (16) , denatured by boiling, and electrophoresed at room temperature on 6% polyacrylamide gel with 8% glycerol in 0.5 Tris-borate-EDTA buffer at 8 W constant power; the dried gels were exposed to Kodak XAR-1 film for autoradiography. PCR fragments that proved positive in the SSCP analysis were cloned into the TA cloning vector (Invitrogen, San Diego, CA) and sequenced using the Sequenase kit (U.S. Biochemicals, Cleveland, OH) and 3 2~-d~~~. After identification of a point mutation in the COLlAl cDNA from the index case, fetus 11, PCR amplification followed by restriction enzyme digestion (with MboI) was used to demonstrate the presence or absence of the mutation in the fibroblast cDNA of both fetuses I1 and IV, DNA extracted from peripheral blood of both parents and healthy controls, and DNA extracted from buccal mucosal cells of the mother. Digested PCR fragments were electrophoresed in 4% NuSieve agarose (FMC Bioproducts, New York, NY)/ethidium bromide or in 10% polyacrylamide gels and visualized under UV light or by silver staining (SilverStain-Plus; BioRad, Hercules, CA), respectively.
RESULTS

Collagen synthesis in cultures of normal AFC and normal
CVCgrown for 3 wk. In accordance with earlier reports (9, lo), we found that AFC produced only type I collagen homotrimers, consisting of al(1)-chains that were highly overmodified (Fig. 3) , whereas CVC were similar to fibroblast cultures in terms of the relative proportions of collagens I, 111, and V and of posttranslational modification of collagen a-chains (Fig. 3) (see below) .
Collagen analysis in normal CVOC. After pepsin extraction of CVOC, collagens I, 111, and V were detectable by SDS-PAGE and Coomassie Blue staining (demonstrating collagens already deposited in the extracellular matrix of CV; not shown) as well as by autoradiofluorography (identifying collagens synthesized during short-term culture; Fig. 3 ). The CVOC incubation medium did not contain significant amounts of collagen (not shown); hence, CV were homogenized and processed together with their supernatant (equivalent to a combination of cell layer and culture medium). Coomassie Blue staining of the gels was performed on d 3 (not shown), and autoradiofluorograms were obtained on d 5. We did not observe major discrepancies between the two visualization methods.
Comparison of collagens synthesized by cultured normal fibroblasts, CVC, and control CVOC. In collagen extracted from CVOC, the ratio of al(1)-to a2(I)-chains was consistently higher than 2:1, indicating the presence of al(1)-homotrimers (Fig. 3) . In addition, the ratio of collagen I11 to collagen I was higher in CVOC than in dermal fibroblasts. The a-chains of all collagen types from CVOC migrated slightly faster than those from cultured fibroblasts and CVC, indicating a lower degree of posttranslational modification. Cells cultivated from the CVS and examined after 3 wk of culture synthesized collagens appearing similar to those from dermal fibroblasts with respect to relative amounts, modification, and chain composition (Fig. 3 ). Besides these differences, which might be attributed to the more physiologic conditions of an organ culture as opposed to a cell culture, we did not observe any migration abnormalities of a-chains from the 11 control CVOC. In all CVS, de novo collagen synthesis was sufficient to allow rapid autoradiographic detection of collagens I, 111, and V and demonstrated collagens deposited in vivo.
Biochemical findings in CVOC of pregnancies at risk. In none of the five pregnancies at risk for 0 1 type I1 were the characteristic electrophoretic abnormalities (Table 1) detected, and the fetuses were presumed to be unaffected by 01, with the reservation that our method was experimental. All pregnancies were subsequently monitored by ultrasound examinations. No abnormalities were detected, and healthy children were delivered in all instances. In CVS from the two pregnancies at risk for EDS IV, the additional collagen 111 band previously observed in fibroblasts cultured from the affected mother (unpublished manuscript) was not observed. Similarly, in the CVS from the pregnancy at risk for EDS VIIB, the characteristic pNa2(I)-doublet present in the affected father was absent (Table 1) . Unaffected fetuses were predicted and no signs of EDS were present at birth or on follow-up examination of the three children.
Biochemical and ultrasonographic findings in family MED. Collagen analysis of fibroblasts established from the index case, fetus 11, showed impaired secretion and increased retention of collagen I (Fig. 2) , with retarded electrophoretic mobility of both al(1)-and a2(I)-chains. Two-dimensional cyanogen bromide-peptide mapping localized the focus of overmodification to the CB8 peptide of the al(1)-collagen chain or the corresponding region of the a2(I)-chain (Fig. 4, lane 2) . Collagen analyzed from a CVS at wk 11 of the third pregnancy was normal (fetus 111, Fig. 2 ), whereas analysis of CVS obtained at wk 11 of the fourth pregnancy revealed retarded migration of both al(1)-and a2(I)-chains (fetus IV, Fig. 2) . The electrophoretic pattern was similar to that previously obtained from skin fibroblasts of fetus I1 (Fig. 2) .
In view of the biochemical findings, ultrasound was repeated at wk 14 ( Fig. 1, right column) and revealed hypomineralization of the skull with enhanced visualization of cerebral structures. The head was soft and could be easily deformed by pressure of the ultrasonic transducer (compare with Fig. 1, left column) (17, 18) . The deformed ribs showed bilateral angular impressions (Fig.  1, right column) . The right femur was bowed and shortened, and deformation and fractures of the left tibia and femur were visible (Fig. 1, right column) . Radiographic examination of the aborted fetus IV confirmed hypomineralization of the skeleton and presence of thin, beaded ribs and bowed femurs (not shown).
Dermal fibroblast cultures established from fetus IV showed the same abnormal biochemical findings as in . Two-dimensional mapping of cyanogen bromide-derived peptides from collagen I produced by cultured fibroblasts from a control and fetuses I1 and IV and by CVOC of fetus IV. Extracted collagens were run in the first dimension as described in Methods. The gel portions corresponding to the collagen a(1)-chains were excised, and collagens were cleaved with cyanogen bromide and electrophoresed in the second dimension on a 10% gel. The peptides appear as round spots in the control, whereas in fibroblasts of fetuses I1 and IV and CVOC of fetus IV a similar pattern with slightly tilted CB7 and markedly tilted CB8 spots is evident. (Note: The rightmost lane had to be exposed for 4 mo due the small amount of material available.) fetus I1 (Fig. 2) . Accordingly, two-dimensional analysis of both fibroblasts and CVOC from fetus IV revealed an abnormal peptide pattern similar to that detected in the index case, fetus I1 (Fig. 4, lanes 3 and 4) . Mutation idmtification in family MED. A PCR fragment encompassing codons 323 to 432 of pro-al(1)-chains, amplified from fibroblast cDNA of fetus 11, showed an abnormal migration pattern on SSCP analysis. Cloning and sequencing of this PCR product showed, in four of seven clones, a G-to-T transition at the second position of codon 355, predicting the change from a glycine to an aspartic acid residue (Fig. 5) . The sequence modification from GGTC to GATC created a new MboI restriction site, the presence of which was used to confirm this mutation at the cDNA level in fetuses I1 and IV. Genomic DNA samples were then PCR-amplified using primers positioned in exon 23 and intron 23, incubated with MboI, and analyzed by electrophoresis (Fig. 6 ). Arnplificates from control blood DNA and the father's blood DNA were not cleaved, amplificates from fibroblast DNA from fetuses I1 and IV were cleaved to yield bands of approximately equal amounts, and amplificates from mother's DNA were cleaved to an extent that was notably less than in both fetuses. The results are consistent with heterozygosity for an 0 1 mutation in both fetuses and mosaic heterozygosity in the mother.
DISCUSSION
The biochemical search for collagen defects, previously limited to the study of dermal fibroblast cultures in the postnatal period, has become the method of choice for the diagnostic confirmation of 0 1 and certain types of EDS in index patients because it is reliable, relatively rapid, and sensitive. Although a similar biochemical approach to prenatal diagnosis of 0 1 and other collagen disorders would be desirable, early studies have shown that AFC synthesize homotrimeric collagen molecules with excessive posttranslational modification, making it
G to A n o r m a l m u t a n t (GGT) Gly -355 -Asp (GAT) Figure 5 . DNA sequence analysis of normal and mutant COLlAl cDNA clones from fetus 11. The normal sequence is shown on the lefr. The mutant clone (right) contains a G-to-A transition (arrowhead) that converts codon 355 of the triple-helical domain from GGT (glycine) to GAT (aspartate). Note also that the mutation creates a restriction site for MboI (GATC) that is not present in the normal sequence and that was used to demonstrate the presence or absence of the mutation (Fig. 6) . impossible to ascertain the presence of a structural defect (9, 10) . Furthermore, CVC have been reported to produce heterotrimeric, albeit also overmodified, collagen (11). To circumvent this problem, we attempted prenatal diagnosis by direct biochemical analysis of isolated, whole CV. We have found that their extracellular matrix (stroma) contains significant amounts of collagen I and collagen I11 deposited in vivo and that they synthesize de novo sufficient amounts of collagen during metabolic labeling in short-term culture (CVOC) for analysis. These collagen populations can be extracted by pepsin digestion and visualized after SDS-PAGE. Although Coomassie blue staining of collagens formed in vivo was not as sensitive as autofluorographic identification of radioactive newly synthesized collagens, it provided preliminary information on the second day after receipt of samples and represented a safety step in case of metabolic failure of the biopsies (an event that we have not encountered so far). We subsequently performed CVOC collagen analysis in a total of 21 pregnancies without encountering technical difficulties. Our preliminary studies showed that, in contrast to earlier findings (ll), collagens synthesized by cultured CVC are similar to those produced by cultured fibroblasts. Cultured CVC therefore appear also to be suitable for prenatal collagen analysis, and they have been used for prenatal diagnosis of 0 1 by other groups (19) . However, because it takes several weeks to grow enough CVC for biochemical analysis, CVOC analysis is certainly preferable, because it provides final results by the fourth day after receipt of specimens and because it avoids the risk of maternal cell growth in cultured CVC.
CVOC analysis allowed us to correctly predict unaffected fetuses in seven pregnancies from five families at risk for EDS IV, EDS VII, and 01. In an additional family reported here, both an unaffected and an affected 0 1 fetus were correctly predicted in consecutive pregnan-cies, and the underlying collagen I defect was determined. The responsible mutation is novel and adds to five other Gly-vAsp substitutions in the al(I)-chain, all of which have been lethal regardless of their position along the triple-helical domain (1). The mother was demonstrated to be mosaic for this mutation. Interestingly, although she had a readily detectable proportion of cells bearing this mutation in blood and oral mucosa, she showed no clinical features of 01 aside from a shorter stature compared with her first-degree relatives. The findings emphasize the indication for prenatal diagnosis in families in which one offspring is affected by OJ type II; birth of a second child with OJ caused by a dominant collagen mutation should be regarded as highly suggestive for parental gonadal (if not somatic) mosaicism and implies a recurrence risk for future pregnancies possibly as high as 50%.
Our prenatal biochemical diagnosis at wk 11 of severe 01 was 3 wk ahead of its confirmation by ultrasonography around wk 14, which is currently the earliest time point for the diagnosis of skeletal abnormalities (6, 19, 20) . However, until more experience with CVOC is available, we suggest waiting for ultrasonographic confirmation by an alerted expert before pregnancy termination rather than acting on the basis of positive CVOC findings alone. Neither should CVOC analysis serve as a prenatal screening method; it is designed and suitable only for collagen I and III defects that have been previously biochemically characterized in each individual family, i.e. in an affected sibling or a parent. In such circumstances, collagen analysis by CVOC might become a rapid and reliable method for prenatal diagnosis.
